Short description
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Description
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases. The company is values-based and deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious diseases. They offer products for treating illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Thousand Oaks, California, United States, North America
Founded on
January 1, 1980
Exited on
June 24, 1983
Went public on
June 24, 1983
Stock symbol
AMGN
Non-profit?
No
Acquired?
No
Employees count
5001+
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noway Youcantaccess, Noway Youcantaccess
Sign in for full access
Founders
George Rathmann
Funding rounds count
18
Portfolio organisations count
Cannot Access, No Way
Sign in for full access
Lead investments count
7
Exits count
Cannot Access, Noaccess
Sign in for full access
IPO exits count
8